(HLIO) Helios Technologies - Overview
Stock: Valves, Hydraulics, Controls, Displays, Instrumentation
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.93% |
| Yield on Cost 5y | 0.60% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 88.1% |
| Payout Ratio | 24.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 45.6% |
| Relative Tail Risk | -16.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.15 |
| Alpha | 48.27 |
| Character TTM | |
|---|---|
| Beta | 1.356 |
| Beta Downside | 1.505 |
| Drawdowns 3y | |
|---|---|
| Max DD | 63.83% |
| CAGR/Max DD | 0.06 |
Description: HLIO Helios Technologies January 15, 2026
Helios Technologies, Inc. (NYSE:HLIO) delivers engineered motion-control and electronic-control solutions worldwide, operating through two primary segments: Hydraulics and Electronics.
The Hydraulics segment manufactures cartridge valves, quick-release couplings, and related fluid-control components for industrial, mobile, agricultural, and construction-equipment applications. Brands such as Sun Hydraulics, Faster, and Custom Fluidpower serve OEMs and value-added distributors. In FY 2023 the segment generated roughly $78 million in revenue, up about 9% year-over-year, reflecting strong demand in the construction-equipment market.
The Electronics segment provides displays, controls, and instrumentation for off-highway vehicles, powersports, marine, agricultural, and power-generation equipment. Products are sold under Enovation Controls, Murphy, Zero Off, and other brands. FY 2023 electronic sales grew to approximately $37 million, driven by a 12% increase in aftermarket upgrades for specialty vehicles.
Helios reaches customers via a mix of direct OEM sales, value-added distributors, and system integrators. The company, originally Sun Hydraulics, rebranded in June 2019 and is headquartered in Sarasota, Florida. The broader industrial hydraulics market is projected to expand at a ~5% CAGR through 2028, supported by rising infrastructure spending and mechanization in agriculture.
For a deeper quantitative assessment, you may find ValueRay’s platform useful for digging into Helios’s financial metrics and peer comparisons.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 33.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.06 > 1.0 |
| NWC/Revenue: 36.62% < 20% (prev 33.17%; Δ 3.45% < -1%) |
| CFO/TA 0.08 > 3% & CFO 117.0m > Net Income 33.8m |
| Net Debt (382.5m) to EBITDA (137.8m): 2.78 < 3 |
| Current Ratio: 2.93 > 1.5 & < 3 |
| Outstanding Shares: last quarter (33.3m) vs 12m ago 0.30% < -2% |
| Gross Margin: 31.49% > 18% (prev 0.31%; Δ 3118 % > 0.5%) |
| Asset Turnover: 51.66% > 50% (prev 52.16%; Δ -0.50% > 0%) |
| Interest Coverage Ratio: 2.52 > 6 (EBITDA TTM 137.8m / Interest Expense TTM 29.4m) |
Altman Z'' 3.46
| A: 0.19 (Total Current Assets 449.0m - Total Current Liabilities 153.2m) / Total Assets 1.56b |
| B: 0.34 (Retained Earnings 522.6m / Total Assets 1.56b) |
| C: 0.05 (EBIT TTM 74.2m / Avg Total Assets 1.56b) |
| D: 0.76 (Book Value of Equity 485.2m / Total Liabilities 637.9m) |
| Altman-Z'' Score: 3.46 = A |
Beneish M -3.03
| DSRI: 1.12 (Receivables 133.7m/120.8m, Revenue 807.8m/819.8m) |
| GMI: 0.98 (GM 31.49% / 30.92%) |
| AQI: 0.96 (AQ_t 0.58 / AQ_t-1 0.60) |
| SGI: 0.99 (Revenue 807.8m / 819.8m) |
| TATA: -0.05 (NI 33.8m - CFO 117.0m) / TA 1.56b) |
| Beneish M-Score: -3.03 (Cap -4..+1) = AA |
What is the price of HLIO shares?
Over the past week, the price has changed by +11.95%, over one month by +22.15%, over three months by +29.60% and over the past year by +68.61%.
Is HLIO a buy, sell or hold?
- StrongBuy: 3
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the HLIO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 70.8 | -2.3% |
| Analysts Target Price | 70.8 | -2.3% |
| ValueRay Target Price | 86.6 | 19.4% |
HLIO Fundamental Data Overview February 03, 2026
P/E Forward = 11.7925
P/S = 2.659
P/B = 2.3802
P/EG = 0.9935
Revenue TTM = 807.8m USD
EBIT TTM = 74.2m USD
EBITDA TTM = 137.8m USD
Long Term Debt = 400.6m USD (from longTermDebt, last quarter)
Short Term Debt = 22.8m USD (from shortTermDebt, last quarter)
Debt = 437.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 382.5m USD (from netDebt column, last quarter)
Enterprise Value = 2.53b USD (2.15b + Debt 437.4m - CCE 54.9m)
Interest Coverage Ratio = 2.52 (Ebit TTM 74.2m / Interest Expense TTM 29.4m)
EV/FCF = 28.14x (Enterprise Value 2.53b / FCF TTM 89.9m)
FCF Yield = 3.55% (FCF TTM 89.9m / Enterprise Value 2.53b)
FCF Margin = 11.13% (FCF TTM 89.9m / Revenue TTM 807.8m)
Net Margin = 4.18% (Net Income TTM 33.8m / Revenue TTM 807.8m)
Gross Margin = 31.49% ((Revenue TTM 807.8m - Cost of Revenue TTM 553.4m) / Revenue TTM)
Gross Margin QoQ = 33.14% (prev 31.76%)
Tobins Q-Ratio = 1.63 (Enterprise Value 2.53b / Total Assets 1.56b)
Interest Expense / Debt = 1.58% (Interest Expense 6.90m / Debt 437.4m)
Taxrate = 19.53% (2.50m / 12.8m)
NOPAT = 59.7m (EBIT 74.2m * (1 - 19.53%))
Current Ratio = 2.93 (Total Current Assets 449.0m / Total Current Liabilities 153.2m)
Debt / Equity = 0.48 (Debt 437.4m / totalStockholderEquity, last quarter 917.9m)
Debt / EBITDA = 2.78 (Net Debt 382.5m / EBITDA 137.8m)
Debt / FCF = 4.25 (Net Debt 382.5m / FCF TTM 89.9m)
Total Stockholder Equity = 893.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.16% (Net Income 33.8m / Total Assets 1.56b)
RoE = 3.78% (Net Income TTM 33.8m / Total Stockholder Equity 893.8m)
RoCE = 5.73% (EBIT 74.2m / Capital Employed (Equity 893.8m + L.T.Debt 400.6m))
RoIC = 4.52% (NOPAT 59.7m / Invested Capital 1.32b)
WACC = 9.28% (E(2.15b)/V(2.59b) * Re(10.91%) + D(437.4m)/V(2.59b) * Rd(1.58%) * (1-Tc(0.20)))
Discount Rate = 10.91% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.30%
[DCF Debug] Terminal Value 72.87% ; FCFF base≈89.9m ; Y1≈86.5m ; Y5≈84.7m
Fair Price DCF = 24.76 (EV 1.20b - Net Debt 382.5m = Equity 820.4m / Shares 33.1m; r=9.28% [WACC]; 5y FCF grow -5.12% → 2.90% )
EPS Correlation: -79.87 | EPS CAGR: -55.13% | SUE: -4.0 | # QB: 0
Revenue Correlation: -44.56 | Revenue CAGR: 0.32% | SUE: 0.94 | # QB: 3
EPS next Quarter (2026-03-31): EPS=0.60 | Chg30d=+0.020 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=2.75 | Chg30d=+0.022 | Revisions Net=+0 | Growth EPS=+11.5% | Growth Revenue=+1.5%